• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UNKNOWN FOLEY CATHETER; CATHETER, RETENTION TYPE, BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UNKNOWN FOLEY CATHETER; CATHETER, RETENTION TYPE, BALLOON Back to Search Results
Patient Problems Urinary Tract Infection (2120); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 03/04/2024
Event Type  Injury  
Event Description
Per pt's wife, she reported that he went to the er for uti about a month ago (she was not sure of exact dates), she stated that they did admit him to the hospital for about 3 days due to him having a-fib and tested positive for covid as well.He completed his course of cipro and is feeling better now, no other new meds were added, no other issues to report.She stated that he has a foley catheter so he gets uti's often.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOLEY CATHETER
Type of Device
CATHETER, RETENTION TYPE, BALLOON
Manufacturer (Section D)
UNKNOWN
MDR Report Key19042356
MDR Text Key339506824
Report NumberMW5153539
Device Sequence Number1
Product Code EZL
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 04/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/03/2024
Patient Sequence Number1
Treatment
ASPIRIN 81 MG.; ATORVASTATIN.; CARBIDOPA/LEVODOPA.; METOPROLOL ER.; NUPLAZID.; TYLENOL.; VITAMIN D3.; XARELTO.
Patient Outcome(s) Hospitalization;
Patient Age84 YR
Patient SexMale
-
-